These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
DELAWARE
|
|
47-2783641
|
|
(State or other Jurisdiction of Incorporation or Organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
||
|
1200 EAST MARKET STREET, SUITE 650
|
|
|
|
AKRON, OHIO
|
|
44305
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, $0.01 par value
|
BW
|
New York Stock Exchange
|
|
Large accelerated filer
|
|
¨
|
|
Accelerated filer
|
|
¨
|
|
|
|
|
|
|||
|
Non-accelerated filer
|
|
x
|
|
Smaller reporting company
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
¨
|
|
|
|
PAGE
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
Three months ended March 31,
|
|||||
|
(in thousands, except per share amounts)
|
2020
|
2019
|
||||
|
Revenues
|
$
|
148,554
|
|
$
|
231,936
|
|
|
Costs and expenses:
|
|
|
||||
|
Cost of operations
|
114,628
|
|
201,067
|
|
||
|
Selling, general and administrative expenses
|
37,608
|
|
42,399
|
|
||
|
Advisory fees and settlement costs
|
4,239
|
|
13,610
|
|
||
|
Restructuring activities and spin-off transaction costs
|
1,951
|
|
6,079
|
|
||
|
Research and development costs
|
1,341
|
|
743
|
|
||
|
Gain on asset disposals, net
|
(915
|
)
|
—
|
|
||
|
Total costs and expenses
|
158,852
|
|
263,898
|
|
||
|
Operating loss
|
(10,298
|
)
|
(31,962
|
)
|
||
|
Other (expense) income:
|
|
|
||||
|
Interest expense
|
(22,091
|
)
|
(11,134
|
)
|
||
|
Interest income
|
40
|
|
559
|
|
||
|
Benefit plans, net
|
7,536
|
|
3,030
|
|
||
|
Foreign exchange
|
(9,326
|
)
|
(10,153
|
)
|
||
|
Other – net
|
(206
|
)
|
420
|
|
||
|
Total other expense
|
(24,047
|
)
|
(17,278
|
)
|
||
|
Loss before income tax (benefit) expense
|
(34,345
|
)
|
(49,240
|
)
|
||
|
Income tax (benefit) expense
|
(810
|
)
|
626
|
|
||
|
Loss from continuing operations
|
(33,535
|
)
|
(49,866
|
)
|
||
|
Income from discontinued operations, net of tax
|
1,913
|
|
—
|
|
||
|
Net loss
|
(31,622
|
)
|
(49,866
|
)
|
||
|
Net income attributable to non-controlling interest
|
96
|
|
101
|
|
||
|
Net loss attributable to stockholders
|
$
|
(31,526
|
)
|
$
|
(49,765
|
)
|
|
|
|
|
||||
|
Basic and diluted loss per share - continuing operations
|
$
|
(0.72
|
)
|
$
|
(2.71
|
)
|
|
Basic and diluted earnings per share - discontinued operations
|
0.04
|
|
—
|
|
||
|
Basic and diluted loss per share
|
$
|
(0.68
|
)
|
$
|
(2.71
|
)
|
|
|
|
|
||||
|
Shares used in the computation of (loss) earnings per share:
|
|
|
|
|
||
|
Basic and diluted
(1)
|
46,403
|
|
18,359
|
|
||
|
|
Three months ended March 31,
|
|||||
|
(in thousands)
|
2020
|
2019
|
||||
|
Net loss
|
$
|
(31,622
|
)
|
$
|
(49,866
|
)
|
|
Other comprehensive income (loss):
|
|
|
||||
|
Currency translation adjustments (CTA)
|
2,380
|
|
10,260
|
|
||
|
|
|
|
||||
|
Derivative financial instruments:
|
|
|
||||
|
Unrealized (gains) losses on derivative financial instruments
|
—
|
|
(1,311
|
)
|
||
|
Income tax benefit
|
—
|
|
(133
|
)
|
||
|
Unrealized (gains) losses on derivative financial instruments, net of taxes
|
—
|
|
(1,178
|
)
|
||
|
Derivative financial instrument losses (gains) reclassified into net loss
|
—
|
|
289
|
|
||
|
Income tax expense
|
—
|
|
65
|
|
||
|
Reclassification adjustment for losses (gains) included in net loss, net of taxes
|
—
|
|
224
|
|
||
|
|
|
|
||||
|
Benefit obligations:
|
|
|
||||
|
Amortization of benefit plan benefits
|
(246
|
)
|
(356
|
)
|
||
|
|
|
|
||||
|
Other comprehensive income
|
2,134
|
|
8,950
|
|
||
|
Total comprehensive loss
|
(29,488
|
)
|
(40,916
|
)
|
||
|
Comprehensive income attributable to non-controlling interest
|
154
|
|
122
|
|
||
|
Comprehensive loss attributable to stockholders
|
$
|
(29,334
|
)
|
$
|
(40,794
|
)
|
|
(in thousands, except per share amount)
|
March 31, 2020
|
December 31, 2019
|
||||
|
Cash and cash equivalents
|
$
|
35,384
|
|
$
|
43,772
|
|
|
Restricted cash and cash equivalents
|
11,001
|
|
13,169
|
|
||
|
Accounts receivable – trade, net
|
139,252
|
|
142,201
|
|
||
|
Accounts receivable – other
|
22,682
|
|
23,263
|
|
||
|
Contracts in progress
|
83,558
|
|
91,579
|
|
||
|
Inventories
|
60,713
|
|
63,103
|
|
||
|
Other current assets
|
24,588
|
|
27,044
|
|
||
|
Current assets held for sale
|
7,038
|
|
8,089
|
|
||
|
Total current assets
|
384,216
|
|
412,220
|
|
||
|
Net property, plant and equipment, and finance lease
|
94,803
|
|
97,053
|
|
||
|
Goodwill
|
46,961
|
|
47,160
|
|
||
|
Intangible assets
|
24,332
|
|
25,300
|
|
||
|
Right-of-use assets
|
12,185
|
|
12,498
|
|
||
|
Other assets
|
26,413
|
|
24,966
|
|
||
|
Non-current assets held for sale
|
7,199
|
|
7,322
|
|
||
|
Total assets
|
$
|
596,109
|
|
$
|
626,519
|
|
|
|
|
|
|
|
||
|
Revolving credit facilities
|
$
|
—
|
|
$
|
179,000
|
|
|
Last out term loans
|
—
|
|
103,953
|
|
||
|
Financing lease liabilities
|
787
|
|
—
|
|
||
|
Accounts payable
|
84,629
|
|
109,913
|
|
||
|
Accrued employee benefits
|
16,068
|
|
18,256
|
|
||
|
Advance billings on contracts
|
68,050
|
|
75,287
|
|
||
|
Accrued warranty expense
|
30,953
|
|
33,376
|
|
||
|
Operating lease liabilities
|
4,346
|
|
4,323
|
|
||
|
Other accrued liabilities
|
75,292
|
|
68,848
|
|
||
|
Current liabilities held for sale
|
8,286
|
|
9,538
|
|
||
|
Total current liabilities
|
288,411
|
|
602,494
|
|
||
|
Revolving credit facilities
|
185,000
|
|
—
|
|
||
|
Last out term loans
|
136,103
|
|
—
|
|
||
|
Pension and other accumulated postretirement benefit liabilities
|
251,355
|
|
259,272
|
|
||
|
Non-current finance lease liabilities
|
30,358
|
|
30,454
|
|
||
|
Non-current operating lease liabilities
|
8,092
|
|
8,388
|
|
||
|
Other non-current liabilities
|
20,404
|
|
20,850
|
|
||
|
Non-current liabilities held for sale
|
36
|
|
—
|
|
||
|
Total liabilities
|
919,759
|
|
921,458
|
|
||
|
Commitments and contingencies
|
|
|
||||
|
Stockholders' deficit:
|
|
|
||||
|
Common stock, par value $0.01 per share, authorized shares of 500,000; issued and outstanding shares of 46,407 and 46,374 at March 31, 2020 and December 31, 2019, respectively
|
4,703
|
|
4,699
|
|
||
|
Capital in excess of par value
|
1,143,490
|
|
1,142,614
|
|
||
|
Treasury stock at cost, 619 and 616 shares at March 31, 2020 and December 31, 2019, respectively
|
(105,716
|
)
|
(105,707
|
)
|
||
|
Accumulated deficit
|
(1,371,414
|
)
|
(1,339,888
|
)
|
||
|
Accumulated other comprehensive income
|
4,060
|
|
1,926
|
|
||
|
Stockholders' deficit attributable to shareholders
|
(324,877
|
)
|
(296,356
|
)
|
||
|
Non-controlling interest
|
1,227
|
|
1,417
|
|
||
|
Total stockholders' deficit
|
(323,650
|
)
|
(294,939
|
)
|
||
|
Total liabilities and stockholders' deficit
|
$
|
596,109
|
|
$
|
626,519
|
|
|
|
Common Stock
|
Capital In
Excess of Par Value |
Treasury Stock
|
Accumulated Deficit
|
Accumulated
Other Comprehensive (Loss) Income |
Non-controlling
Interest |
Total
Stockholders’ Deficit |
||||||||||||||||
|
|
|||||||||||||||||||||||
|
|
Shares
(1)
|
Par Value
|
|||||||||||||||||||||
|
|
|
(in thousands, except share and per share amounts)
|
|||||||||||||||||||||
|
Balance at December 31, 2018
|
16,879
|
|
$
|
1,748
|
|
$
|
1,047,062
|
|
$
|
(105,590
|
)
|
$
|
(1,217,914
|
)
|
$
|
(11,432
|
)
|
$
|
8,829
|
|
$
|
(277,297
|
)
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Net loss
|
—
|
|
—
|
|
—
|
|
—
|
|
(49,765
|
)
|
—
|
|
(101
|
)
|
(49,866
|
)
|
|||||||
|
Currency translation adjustments
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
10,260
|
|
(21
|
)
|
10,239
|
|
|||||||
|
Derivative financial instruments
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(954
|
)
|
—
|
|
(954
|
)
|
|||||||
|
Defined benefit obligations
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(356
|
)
|
—
|
|
(356
|
)
|
|||||||
|
Stock-based compensation charges
|
7
|
|
—
|
|
404
|
|
(22
|
)
|
—
|
|
—
|
|
—
|
|
382
|
|
|||||||
|
Balance at March 31, 2019
|
16,886
|
|
$
|
1,748
|
|
$
|
1,047,466
|
|
$
|
(105,612
|
)
|
$
|
(1,267,679
|
)
|
$
|
(2,482
|
)
|
$
|
8,707
|
|
$
|
(317,852
|
)
|
|
|
Common Stock
|
Capital In
Excess of Par Value |
Treasury Stock
|
Accumulated Deficit
|
Accumulated
Other Comprehensive Income (Loss) |
Non-controlling
Interest |
Total
Stockholders’ Deficit |
||||||||||||||||
|
|
|||||||||||||||||||||||
|
|
Shares
|
Par Value
|
|||||||||||||||||||||
|
|
|
(in thousands, except share and per share amounts)
|
|||||||||||||||||||||
|
Balance at December 31, 2019
|
46,374
|
|
$
|
4,699
|
|
$
|
1,142,614
|
|
$
|
(105,707
|
)
|
$
|
(1,339,888
|
)
|
$
|
1,926
|
|
$
|
1,417
|
|
$
|
(294,939
|
)
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Net loss
|
—
|
|
—
|
|
—
|
|
—
|
|
(31,526
|
)
|
—
|
|
(96
|
)
|
(31,622
|
)
|
|||||||
|
Currency translation adjustments
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
2,380
|
|
(58
|
)
|
2,322
|
|
|||||||
|
Defined benefit obligations
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(246
|
)
|
—
|
|
(246
|
)
|
|||||||
|
Stock-based compensation charges
|
33
|
|
4
|
|
876
|
|
(9
|
)
|
—
|
|
—
|
|
—
|
|
871
|
|
|||||||
|
Dividends to non-controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(36
|
)
|
(36
|
)
|
|||||||
|
Balance at March 31, 2020
|
46,407
|
|
$
|
4,703
|
|
$
|
1,143,490
|
|
$
|
(105,716
|
)
|
$
|
(1,371,414
|
)
|
$
|
4,060
|
|
$
|
1,227
|
|
$
|
(323,650
|
)
|
|
|
Three months ended March 31,
|
|||||
|
(in thousands)
|
2020
|
2019
|
||||
|
Cash flows from operating activities:
|
|
|||||
|
Net loss
|
$
|
(31,622
|
)
|
$
|
(49,866
|
)
|
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
|
|
||||
|
Depreciation and amortization of long-lived assets
|
4,208
|
|
7,306
|
|
||
|
Amortization of deferred financing costs, debt discount and payment-in-kind interest
|
9,877
|
|
5,695
|
|
||
|
Non-cash operating lease expense
|
1,223
|
|
1,543
|
|
||
|
Gains on asset disposals
|
(915
|
)
|
—
|
|
||
|
Benefit from deferred income taxes, including valuation allowances
|
(424
|
)
|
(175
|
)
|
||
|
Mark to market (gains) losses and prior service cost amortization for pension and postretirement plans
|
(246
|
)
|
42
|
|
||
|
Stock-based compensation, net of associated income taxes
|
880
|
|
404
|
|
||
|
Changes in assets and liabilities:
|
|
|
||||
|
Accounts receivable
|
10,599
|
|
192
|
|
||
|
Contracts in progress
|
7,690
|
|
8,729
|
|
||
|
Advance billings on contracts
|
(7,321
|
)
|
1,165
|
|
||
|
Inventories
|
1,286
|
|
(3,239
|
)
|
||
|
Income taxes
|
(1,888
|
)
|
(49
|
)
|
||
|
Accounts payable
|
(26,451
|
)
|
4,594
|
|
||
|
Accrued and other current liabilities
|
6,110
|
|
6,480
|
|
||
|
Accrued contract loss
|
(2,593
|
)
|
(30,903
|
)
|
||
|
Pension liabilities, accrued postretirement benefits and employee benefits
|
(10,258
|
)
|
(594
|
)
|
||
|
Other, net
|
4,384
|
|
10,980
|
|
||
|
Net cash used in operating activities
|
(35,461
|
)
|
(37,696
|
)
|
||
|
Cash flows from investing activities:
|
|
|
||||
|
Purchase of property, plant and equipment
|
(2,394
|
)
|
(288
|
)
|
||
|
Purchases of available-for-sale securities
|
(6,352
|
)
|
(6,036
|
)
|
||
|
Sales and maturities of available-for-sale securities
|
3,420
|
|
957
|
|
||
|
Other, net
|
831
|
|
95
|
|
||
|
Net cash used in investing activities
|
(4,495
|
)
|
(5,272
|
)
|
||
|
Cash flows from financing activities:
|
|
|
||||
|
Borrowings under our U.S. revolving credit facility
|
70,200
|
|
71,200
|
|
||
|
Repayments of our U.S. revolving credit facility
|
(64,200
|
)
|
(40,800
|
)
|
||
|
Borrowings under Last Out Term Loan Tranche A-2
|
—
|
|
10,000
|
|
||
|
Borrowings under Last Out Term Loan Tranche A-4
|
30,000
|
|
—
|
|
||
|
Repayments under our foreign revolving credit facilities
|
—
|
|
(600
|
)
|
||
|
Shares of our common stock returned to treasury stock
|
(9
|
)
|
(22
|
)
|
||
|
Debt issuance costs
|
(5,749
|
)
|
(6,675
|
)
|
||
|
Other, net
|
550
|
|
—
|
|
||
|
Net cash from financing activities
|
30,792
|
|
33,103
|
|
||
|
Effects of exchange rate changes on cash
|
(1,392
|
)
|
72
|
|
||
|
Net decrease in cash, cash equivalents and restricted cash
|
(10,556
|
)
|
(9,793
|
)
|
||
|
Cash, cash equivalents and restricted cash, beginning of period
|
56,941
|
|
60,279
|
|
||
|
Cash, cash equivalents and restricted cash, end of period
|
$
|
46,385
|
|
$
|
50,486
|
|
|
•
|
entered into several amendments and waivers to avoid default and improve our liquidity under the terms of our Amended Credit Agreement as described in
Note 13
and
Note 14
, the most recent of which were Amendments No. 19, No. 20 and No. 21 dated January 17, 2020, January 31, 2020 and March 27, 2020, respectively;
|
|
•
|
on January 31, 2020, received
$30.0 million
of additional gross borrowings from B. Riley Financial, Inc. (together with its affiliates, "B. Riley") under a new Tranche A-4 of Last Out Term Loans, as described in in
Note 14
;
|
|
•
|
on January 31, 2020, received an incremental Tranche A-5 of Last Out Term Loan commitment to be used in the event certain customer letters of credit are drawn, as described in
Note 14
;
|
|
•
|
on March 12, 2020, filed for waiver of required minimum contributions to the U.S. Pension Plan as described in
Note 12
, that if granted, would reduce cash funding requirements in 2020 by approximately
$25.0 million
and would
|
|
•
|
on March 17, 2020, we fully settled the remaining escrow associated with the sale of Palm Beach Resource Recovery Corporation ("PBRRC") and received
$4.5 million
in cash.
|
|
•
|
on April 6, 2020, we fully settled the remaining escrow associated with the sale of the MEGTEC and Universal businesses and received
$3.5 million
in cash;
|
|
•
|
in April 2020, as part of the Company’s recent response to the impact of the COVID-19 pandemic on its business, the Company has taken the following cash conservation and cost reduction measures which include:
|
|
◦
|
temporarily deferring the monthly fee paid to BRPI Executive Consulting, LLC for the services of our Chief Executive Officer by
50%
;
|
|
◦
|
deferrals of the base salaries of our Chief Strategy Officer by
50%
, Chief Financial Officer by
30%
and our Senior Vice President of The Babcock & Wilcox Company by
30%
;
|
|
◦
|
approval by the Company’s Board for a temporary deferral of
50%
of the cash compensation payable to non-employee directors under the Company’s board compensation program to be paid during the first quarter of 2021;
|
|
◦
|
negotiating temporary rent payment deferrals related to leased facilities located in the U.S., Canada, Italy and Denmark;
|
|
◦
|
exploring options for government loans and programs in the U.S. and abroad that would be appropriate and available;
|
|
•
|
we elected to defer, in accordance with the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") signed into law in March 2020, the contribution payment of
$5.5 million
for the 2020 Plan year that would have been made on April 15, 2020 related to our Pension Plan; and
|
|
•
|
on May 14, 2020, the Company entered into an agreement with its lenders amending and restating the Amended Credit Agreement, among the Company, Bank of America, N.A., as administrative agent (the "Administrative Agent") and lender, and the other lenders party thereto. The credit agreement, as amended and restated (the “A&R Credit Agreement”), among other amendments, extends the maturity date on the revolving credit facility to June 30, 2022 and the maturity date on the last out term loans (the "Last Out Term Loans") to December 30, 2022. Under the A&R Credit Agreement, B. Riley has committed to provide the Company with up to
$70.0 million
of additional Last Out Term Loans. B. Riley has also agreed to enter into a limited guaranty (the "B. Riley Guaranty") which provides for the guarantee of all of the Company's obligations with respect to the revolving credit facility (other than with respect to letters of credit and contingent obligations), including the obligation to repay outstanding revolving credit loans and pay earned interest and fees. For more information regarding the A&R Credit Agreement and the additional last out term loans being provided by B. Riley, see Note 23.
|
|
|
Three months ended March 31,
|
|||||
|
(in thousands, except per share amounts)
|
2020
|
2019
|
||||
|
Loss from continuing operations
|
$
|
(33,439
|
)
|
$
|
(49,765
|
)
|
|
Income from discontinued operations, net of tax
|
1,913
|
|
—
|
|
||
|
Net loss attributable to stockholders
|
$
|
(31,526
|
)
|
$
|
(49,765
|
)
|
|
|
|
|
||||
|
Weighted average shares used to calculate basic and diluted earnings per share
(1)
|
46,403
|
|
18,359
|
|
||
|
|
|
|
||||
|
Basic and diluted loss per share - continuing operations
|
$
|
(0.72
|
)
|
$
|
(2.71
|
)
|
|
Basic and diluted earnings per share - discontinued operations
|
0.04
|
|
—
|
|
||
|
Basic and diluted loss per share
|
$
|
(0.68
|
)
|
$
|
(2.71
|
)
|
|
•
|
Babcock & Wilcox segment
:
focused on the supply of, and aftermarket services, for steam-generating, environmental and auxiliary equipment for power generation and other industrial applications.
|
|
•
|
Vølund & Other Renewable segment
:
focused on the supply of steam-generating systems, environmental and auxiliary equipment and operations and maintenance services for the waste-to-energy and biomass power generation industries.
|
|
•
|
SPIG segment
:
focused on the supply of custom-engineered cooling systems for steam applications along with related aftermarket services.
|
|
|
Three months ended March 31,
|
|||||
|
(in thousands)
|
2020
|
2019
|
||||
|
Revenues:
|
|
|
||||
|
Babcock & Wilcox segment
|
|
|
||||
|
Retrofits
|
$
|
29,648
|
|
$
|
30,674
|
|
|
New build utility and environmental
|
6,551
|
|
68,907
|
|
||
|
Aftermarket parts and field engineering services
|
63,690
|
|
63,087
|
|
||
|
Industrial steam generation
|
23,557
|
|
47,010
|
|
||
|
Eliminations
|
(1,490
|
)
|
(21,120
|
)
|
||
|
|
121,956
|
|
188,558
|
|
||
|
Vølund & Other Renewable segment
|
|
|
||||
|
Renewable new build and services
|
11,813
|
|
29,533
|
|
||
|
Operations and maintenance services
|
3,498
|
|
560
|
|
||
|
Eliminations
|
(2
|
)
|
(561
|
)
|
||
|
|
15,309
|
|
29,532
|
|
||
|
SPIG segment
|
|
|
||||
|
New build cooling systems
|
7,002
|
|
21,006
|
|
||
|
Aftermarket cooling system services
|
4,339
|
|
8,171
|
|
||
|
Eliminations
|
(4
|
)
|
(275
|
)
|
||
|
|
11,337
|
|
28,902
|
|
||
|
|
|
|
||||
|
Eliminations
|
(48
|
)
|
(15,056
|
)
|
||
|
|
$
|
148,554
|
|
$
|
231,936
|
|
|
|
Three months ended March 31,
|
|||||
|
(in thousands)
|
2020
|
2019
|
||||
|
Adjusted EBITDA
(1)
|
|
|
|
|
||
|
Babcock & Wilcox segment
|
$
|
10,654
|
|
$
|
9,089
|
|
|
Vølund & Other Renewable segment
|
(3,293
|
)
|
(8,789
|
)
|
||
|
SPIG segment
|
(1,192
|
)
|
658
|
|
||
|
Corporate
|
(4,143
|
)
|
(4,591
|
)
|
||
|
Research and development costs
|
(1,341
|
)
|
(743
|
)
|
||
|
|
685
|
|
(4,376
|
)
|
||
|
|
|
|
|
|
||
|
Restructuring activities and spin-off transaction costs
|
(1,951
|
)
|
(6,079
|
)
|
||
|
Financial advisory services
|
(929
|
)
|
(3,958
|
)
|
||
|
Settlement cost to exit Vølund contract
(2)
|
—
|
|
(6,575
|
)
|
||
|
Advisory fees for settlement costs and liquidity planning
|
(2,614
|
)
|
(3,077
|
)
|
||
|
Litigation legal costs
|
(696
|
)
|
—
|
|
||
|
Stock compensation
|
(712
|
)
|
(591
|
)
|
||
|
Loss from business held for sale
|
(788
|
)
|
—
|
|
||
|
Depreciation & amortization
|
(4,208
|
)
|
(7,306
|
)
|
||
|
Gain on asset disposals, net
|
915
|
|
—
|
|
||
|
Operating loss
|
(10,298
|
)
|
(31,962
|
)
|
||
|
Interest expense, net
|
(22,051
|
)
|
(10,575
|
)
|
||
|
Net pension benefit before MTM
|
7,536
|
|
3,428
|
|
||
|
MTM loss from benefit plans
|
—
|
|
(398
|
)
|
||
|
Foreign exchange
|
(9,326
|
)
|
(10,153
|
)
|
||
|
Other – net
|
(206
|
)
|
420
|
|
||
|
Loss before income tax (benefit) expense
|
$
|
(34,345
|
)
|
$
|
(49,240
|
)
|
|
(2)
|
In March 2019, we entered into a settlement in connection with an additional European waste-to-energy EPC contract, for which notice to proceed was not given and the contract was not started. The settlement eliminates our obligations to act, and our risk related to acting, as the prime EPC should the project have moved forward.
|
|
(in thousands)
|
March 31, 2020
|
December 31, 2019
|
$ Change
|
% Change
|
|||||||
|
Contract assets - included in contracts in progress:
|
|
|
|
|
|||||||
|
Costs incurred less costs of revenue recognized
|
$
|
29,877
|
|
$
|
29,877
|
|
$
|
—
|
|
—
|
%
|
|
Revenues recognized less billings to customers
|
53,681
|
|
61,702
|
|
(8,021
|
)
|
(13
|
)%
|
|||
|
Contracts in progress
|
$
|
83,558
|
|
$
|
91,579
|
|
$
|
(8,021
|
)
|
(9
|
)%
|
|
Contract liabilities - included in advance billings on contracts:
|
|
|
|
|
|||||||
|
Billings to customers less revenues recognized
|
$
|
66,485
|
|
$
|
76,468
|
|
$
|
(9,983
|
)
|
(13
|
)%
|
|
Costs of revenue recognized less cost incurred
|
1,565
|
|
(1,181
|
)
|
2,746
|
|
(233
|
)%
|
|||
|
Advance billings on contracts
|
$
|
68,050
|
|
$
|
75,287
|
|
$
|
(7,237
|
)
|
(10
|
)%
|
|
|
|
|
|
|
|||||||
|
Net contract balance
|
$
|
15,508
|
|
$
|
16,292
|
|
$
|
(784
|
)
|
5
|
%
|
|
|
|
|
|
|
|||||||
|
Accrued contract losses
|
$
|
3,545
|
|
$
|
6,139
|
|
$
|
(2,594
|
)
|
(42
|
)%
|
|
|
Three months ended March 31,
|
|||||
|
(in thousands)
|
2020
|
2019
|
||||
|
Increases in gross profits for changes in estimates for over time contracts
|
$
|
8,182
|
|
$
|
9,525
|
|
|
Decreases in gross profits for changes in estimates for over time contracts
|
(4,845
|
)
|
(9,396
|
)
|
||
|
Net changes in gross profits for changes in estimates for over time contracts
|
$
|
3,337
|
|
$
|
129
|
|
|
•
|
The first contract, a waste-to-energy plant in Denmark, became a loss contract in the second quarter of 2016. As of
March 31, 2020
, this contract was approximately
99%
complete and construction activities are complete as of the date of this report. The unit became operational during the second quarter of 2017. A settlement was reached with the customer to achieve takeover on January 31, 2019, after which only punch list items and other agreed to remediation items remain, most of which are expected to be performed during the customer's scheduled maintenance outages. As of January 31, 2019, the contract is in the warranty phase. During the
three months ended
March 31, 2020
, we did
no
t recognize additional contract losses. Our estimate at completion as of
March 31, 2020
includes
$8.9 million
of total estimated liquidated damages. As of
March 31, 2020
, the reserve for estimated contract losses recorded in
other accrued liabilities
in our Consolidated Balance Sheets was
$0.7 million
. In the
three months ended
March 31, 2019
, we did
no
t recognize further charges on the contract. As of
March 31, 2019
, this contract had
$3.6 million
of accrued losses and was
97%
complete.
|
|
•
|
The second contract, a biomass plant in the United Kingdom, became a loss contract in the fourth quarter of 2016. As of
March 31, 2020
, this contract was approximately
100%
complete. Trial operations began in April 2019 and takeover by the customer occurred effective May 2019. This project is subject to the
March 29, 2019
settlement agreement described above. During the
three months ended
March 31, 2020
, we recognized additional contract losses of
$0.1 million
on this contract as a result of additional punch list and other commissioning costs. Our estimate at completion as of
March 31, 2020
includes
$18.7 million
of total estimated liquidated damages due to schedule delays. Our estimates at completion as of
March 31, 2020
and 2019 also include contractual bonus opportunities for guaranteed higher power output and other performance metrics. As of
March 31, 2020
, we expect no future charges due to this contract and, accordingly, have
no
reserve for estimated contract losses. In the
three months ended
March 31, 2019
, we recognized contract losses of
$0.8 million
on this contract as a result of repairs required during startup commissioning activities, additional expected punch list and other commissioning costs, and changes in construction cost estimates. As of
March 31, 2019
, this contract had
$1.4 million
of accrued losses and was
98%
complete.
|
|
•
|
The third contract, a biomass plant in Denmark, became a loss contract in the fourth quarter of 2016. As of
March 31, 2020
, this contract was approximately
100%
complete. Warranty began in March 2018, when we agreed to a partial takeover with the customer, and we agreed to a full takeover by the customer at the end of October 2018, when we also agreed to a scheduled timeline for remaining punch list activities to be completed around the customer's future planned outages. During the three months ended
March 31, 2020
, we did
no
t recognize additional contract losses. Our estimate at completion as of
March 31, 2020
includes
$6.6 million
of total estimated liquidated damages due to schedule delays. As of
March 31, 2020
, we expect no future charges due to this contract and, accordingly, we have
no
reserve for estimated contract losses. In the three months ended
March 31, 2019
, we did
no
t recognize additional contract losses. As of
March 31, 2019
, this contract had
$0.3 million
of accrued losses and was
99%
complete.
|
|
•
|
The fourth contract, a biomass plant in the United Kingdom, became a loss contract in the fourth quarter of 2016. As of
March 31, 2020
, this contract was approximately
100%
complete. Trial operations began in November 2018 and takeover by the customer occurred in February 2019, after which only final performance testing, for which performance metrics have been previously demonstrated, and punch list and other agreed upon items remain, some of which are expected to be performed during the customer's scheduled maintenance outages. During the three
|
|
•
|
The fifth contract, a biomass plant in the United Kingdom, became a loss contract in the second quarter of 2017. As of
March 31, 2020
, this contract was approximately
99%
complete. This project is subject to the
March 29, 2019
settlement agreement described above.
We estimated the portion of this settlement related to waiver of the rejection right on the fifth loss contract was
$81.1 million
, which was recorded in the fourth quarter of 2018 as a reduction in the selling price.
Under the settlement, our remaining performance obligations were limited to construction support services to complete certain key systems of the plant by May 31, 2019. The settlement also eliminated all historical claims and remaining liquidated damages. Remaining items at
March 31, 2020
are primarily related to punch list and other finalization items for the key systems under the terms of the settlement and subcontract close outs. During the three months ended
March 31, 2020
, our estimated loss on the contract improved by
$0.3 million
. Our estimate at completion as of
March 31, 2020
, includes
$13.3 million
of total estimated liquidated damages due to schedule delays. As of
March 31, 2020
, the reserve for estimated contract losses recorded in other accrued liabilities in our Consolidated Balance Sheets was
$0.9 million
. During the three months ended
March 31, 2019
, we recognized contract losses of
$2.3 million
due to a change in the estimate for subcontractor close out costs. As of
March 31, 2019
, this contract had
$15.8 million
of accrued losses and was
90%
complete.
|
|
•
|
The sixth contract, a waste-to-energy plant in the United Kingdom, became a loss contract in the second quarter of 2017. As of
March 31, 2020
, this contract was approximately
99%
complete. Trial operations began in December 2018 and customer takeover occurred on January 25, 2019, after which only final performance testing, for which performance metrics have been previously demonstrated, and punch list and other agreed upon items remain, some of which are expected to be performed during the customer's scheduled maintenance outages. The contract is in the warranty phase. During the three months ended
March 31, 2020
, we did
no
t recognize additional contract losses. Our estimate at completion as of
March 31, 2020
includes
$18.7 million
of total estimated liquidated damages due to schedule delays. As of
March 31, 2020
, the reserve for estimated contract losses recorded in other accrued liabilities in our Consolidated Balance Sheets was
$0.2 million
. In the three months ended
March 31, 2019
, we revised our revenue and costs at completion for this contract, which resulted in additional contract losses of
$0.8 million
related to matters encountered in completing punch list items. As of
March 31, 2019
, this contract had
$0.6 million
of accrued losses and was
98%
complete.
|
|
(in thousands)
|
March 31, 2020
|
December 31, 2019
|
||||
|
Raw materials and supplies
|
$
|
40,659
|
|
$
|
42,685
|
|
|
Work in progress
|
7,224
|
|
7,502
|
|
||
|
Finished goods
|
12,830
|
|
12,916
|
|
||
|
Total inventories
|
$
|
60,713
|
|
$
|
63,103
|
|
|
(in thousands)
|
March 31, 2020
|
December 31, 2019
|
||||
|
Land
|
$
|
2,994
|
|
$
|
2,998
|
|
|
Buildings
|
83,548
|
|
84,005
|
|
||
|
Machinery and equipment
|
152,021
|
|
154,016
|
|
||
|
Property under construction
|
7,063
|
|
6,204
|
|
||
|
|
245,626
|
|
247,223
|
|
||
|
Less accumulated depreciation
|
180,844
|
|
180,562
|
|
||
|
Net property, plant and equipment
|
64,782
|
|
66,661
|
|
||
|
Finance lease
|
30,548
|
|
30,405
|
|
||
|
Less finance lease accumulated amortization
|
527
|
|
13
|
|
||
|
Net property, plant and equipment, and finance lease
|
$
|
94,803
|
|
$
|
97,053
|
|
|
(in thousands)
|
Babcock & Wilcox Segment
|
||
|
Balance at December 31, 2019
|
$
|
47,160
|
|
|
Currency translation adjustments
|
(199
|
)
|
|
|
Balance at March 31, 2020
|
$
|
46,961
|
|
|
(in thousands)
|
March 31, 2020
|
December 31, 2019
|
||||
|
Definite-lived intangible assets
|
|
|
||||
|
Customer relationships
|
$
|
24,414
|
|
$
|
24,440
|
|
|
Unpatented technology
|
14,884
|
|
14,917
|
|
||
|
Patented technology
|
2,596
|
|
2,598
|
|
||
|
Tradename
|
12,350
|
|
12,372
|
|
||
|
All other
|
9,238
|
|
9,225
|
|
||
|
Gross value of definite-lived intangible assets
|
63,482
|
|
63,552
|
|
||
|
Customer relationships amortization
|
(18,886
|
)
|
(18,616
|
)
|
||
|
Unpatented technology amortization
|
(5,609
|
)
|
(5,245
|
)
|
||
|
Patented technology amortization
|
(2,507
|
)
|
(2,476
|
)
|
||
|
Tradename amortization
|
(4,400
|
)
|
(4,257
|
)
|
||
|
All other amortization
|
(9,053
|
)
|
(8,963
|
)
|
||
|
Accumulated amortization
|
(40,455
|
)
|
(39,557
|
)
|
||
|
Net definite-lived intangible assets
|
$
|
23,027
|
|
$
|
23,995
|
|
|
Indefinite-lived intangible assets
|
|
|
||||
|
Trademarks and trade names
|
$
|
1,305
|
|
$
|
1,305
|
|
|
Total intangible assets, net
|
$
|
24,332
|
|
$
|
25,300
|
|
|
|
Three months ended March 31,
|
|||||
|
(in thousands)
|
2020
|
2019
|
||||
|
Balance at beginning of period
|
$
|
25,300
|
|
$
|
30,793
|
|
|
Amortization expense
|
(895
|
)
|
(1,187
|
)
|
||
|
Currency translation adjustments and other
|
(73
|
)
|
(490
|
)
|
||
|
Balance at end of the period
|
$
|
24,332
|
|
$
|
29,116
|
|
|
|
Amortization Expense
|
||
|
Year ending December 31, 2020
|
$
|
2,392
|
|
|
Year ending December 31, 2021
|
3,042
|
|
|
|
Year ending December 31, 2022
|
3,012
|
|
|
|
Year ending December 31, 2023
|
3,011
|
|
|
|
Year ending December 31, 2024
|
2,938
|
|
|
|
Year ending December 31, 2025
|
2,454
|
|
|
|
Thereafter
|
6,178
|
|
|
|
|
|
Three months ended March 31,
|
|||||
|
(in thousands)
|
Classification
|
2020
|
2019
|
||||
|
Operating lease expense:
|
|
|
|
||||
|
Operating lease expense
|
Selling, general and administrative expenses
|
$
|
1,507
|
|
$
|
1,909
|
|
|
Short-term lease expense
|
Selling, general and administrative expenses
|
188
|
|
2,861
|
|
||
|
Variable lease expense
(1)
|
Selling, general and administrative expenses
|
776
|
|
112
|
|
||
|
Total operating lease expense
|
|
$
|
2,471
|
|
$
|
4,882
|
|
|
|
|
|
|
|
|||
|
Finance lease expense:
|
|
|
|
||||
|
Amortization of right-of-use assets
|
Selling, general and administrative expenses
|
$
|
515
|
|
$
|
—
|
|
|
Interest on lease liabilities
|
Interest expense
|
615
|
|
—
|
|
||
|
Total finance lease expense
|
|
$
|
1,130
|
|
$
|
—
|
|
|
|
|
|
|
||||
|
Sublease income
(2)
|
Other – net
|
$
|
(22
|
)
|
$
|
(10
|
)
|
|
Net lease cost
|
|
$
|
3,579
|
|
$
|
4,872
|
|
|
(in thousands)
|
March 31, 2020
|
December 31, 2019
|
||||
|
Cash paid for amounts included in the measurement of lease liabilities:
|
|
|
||||
|
Operating cash flows from operating leases
|
$
|
1,400
|
|
$
|
6,578
|
|
|
Operating cash flows from finance leases
|
615
|
|
14
|
|
||
|
Financing cash flows from finance leases
|
(586
|
)
|
(12
|
)
|
||
|
|
|
|
||||
|
Right-of-use assets obtained in exchange for lease liabilities:
|
|
|
||||
|
Operating leases
|
$
|
927
|
|
$
|
3,014
|
|
|
Finance leases
|
$
|
146
|
|
$
|
30,404
|
|
|
|
|
|
||||
|
Weighted-average remaining lease term:
|
|
|
||||
|
Operating leases (in years)
|
3.3
|
|
3.4
|
|
||
|
Finance leases (in years)
|
14.7
|
|
15.0
|
|
||
|
Weighted-average discount rate:
|
|
|
||||
|
Operating leases
|
9.13
|
%
|
9.27
|
%
|
||
|
Finance leases
|
8.00
|
%
|
8.00
|
%
|
||
|
(in thousands)
|
|
|
|
||||
|
Assets:
|
Classification
|
March 31, 2020
|
December 31, 2019
|
||||
|
Operating lease assets
|
Right-of-use assets
|
$
|
12,185
|
|
$
|
12,498
|
|
|
Finance lease assets
|
Net property, plant and equipment, and finance lease
|
30,021
|
|
30,392
|
|
||
|
Total non-current lease assets
|
|
$
|
42,206
|
|
$
|
42,890
|
|
|
|
|
|
|
||||
|
Liabilities:
|
|
|
|
||||
|
Current
|
|
|
|
||||
|
Operating lease liabilities
|
Operating lease liabilities
|
$
|
4,346
|
|
$
|
4,323
|
|
|
Finance lease liabilities
|
Financing lease liabilities
|
787
|
|
(38
|
)
|
||
|
Non-current
|
|
|
|
||||
|
Operating lease liabilities
|
Non-current operating lease liabilities
|
8,092
|
|
8,388
|
|
||
|
Finance lease liabilities
|
Non-current finance lease liabilities
|
30,358
|
|
30,454
|
|
||
|
Total lease liabilities
|
|
$
|
43,583
|
|
$
|
43,127
|
|
|
(in thousands)
|
Operating Leases
|
Finance Leases
|
Total
|
||||||
|
2020 (excluding the three months ended March 31, 2020)
|
$
|
4,516
|
|
$
|
2,410
|
|
$
|
6,926
|
|
|
2021
|
3,946
|
|
3,277
|
|
7,223
|
|
|||
|
2022
|
2,736
|
|
3,342
|
|
6,078
|
|
|||
|
2023
|
1,832
|
|
3,407
|
|
5,239
|
|
|||
|
2024
|
1,113
|
|
3,472
|
|
4,585
|
|
|||
|
Thereafter
|
105
|
|
38,285
|
|
38,390
|
|
|||
|
Total
|
$
|
14,248
|
|
$
|
54,193
|
|
$
|
68,441
|
|
|
Less imputed interest
|
(1,810
|
)
|
(23,048
|
)
|
(24,858
|
)
|
|||
|
Lease liability
|
$
|
12,438
|
|
$
|
31,145
|
|
$
|
43,583
|
|
|
|
Three months ended March 31,
|
|||||
|
(in thousands)
|
2020
|
2019
|
||||
|
Balance at beginning of period
|
$
|
33,376
|
|
$
|
45,117
|
|
|
Additions
|
1,350
|
|
1,991
|
|
||
|
Expirations and other changes
|
(517
|
)
|
(385
|
)
|
||
|
Payments
|
(3,119
|
)
|
(1,271
|
)
|
||
|
Translation and other
|
(137
|
)
|
(628
|
)
|
||
|
Balance at end of period
|
$
|
30,953
|
|
$
|
44,824
|
|
|
|
Three months ended March 31,
|
|
Three months ended March 31,
|
||||||||||
|
|
2020
|
|
2019
|
||||||||||
|
(in thousands)
|
Total
|
Severance and related costs
|
Other
(1)
|
|
Severance and related costs
|
||||||||
|
Babcock & Wilcox segment
|
$
|
1,323
|
|
$
|
542
|
|
$
|
781
|
|
|
$
|
3,947
|
|
|
Vølund & Other Renewable segment
|
559
|
|
559
|
|
—
|
|
|
578
|
|
||||
|
SPIG segment
|
—
|
|
—
|
|
—
|
|
|
144
|
|
||||
|
Corporate
|
69
|
|
—
|
|
69
|
|
|
1,410
|
|
||||
|
|
$
|
1,951
|
|
$
|
1,101
|
|
$
|
850
|
|
|
$
|
6,079
|
|
|
|
Three months ended March 31,
|
|||||
|
(in thousands)
|
2020
|
2019
|
||||
|
Balance at beginning of period
|
$
|
5,358
|
|
$
|
7,359
|
|
|
Restructuring expense
|
1,951
|
|
6,079
|
|
||
|
Payments
|
(1,968
|
)
|
(3,242
|
)
|
||
|
Balance at end of period
|
$
|
5,341
|
|
$
|
10,196
|
|
|
|
Pension Benefits
|
|
Other Benefits
|
||||||||||
|
|
Three months ended March 31,
|
|
Three months ended March 31,
|
||||||||||
|
(in thousands)
|
2020
|
2019
|
|
2020
|
2019
|
||||||||
|
Interest cost
|
$
|
8,261
|
|
$
|
10,860
|
|
|
$
|
72
|
|
$
|
121
|
|
|
Expected return on plan assets
|
(15,641
|
)
|
(13,920
|
)
|
|
—
|
|
—
|
|
||||
|
Amortization of prior service cost
|
43
|
|
50
|
|
|
(271
|
)
|
(539
|
)
|
||||
|
Recognized net actuarial (gain) loss
|
—
|
|
398
|
|
|
—
|
|
—
|
|
||||
|
Benefit plans, net
(1)
|
(7,337
|
)
|
(2,612
|
)
|
|
(199
|
)
|
(418
|
)
|
||||
|
Service cost included in COS
(2)
|
211
|
|
217
|
|
|
5
|
|
4
|
|
||||
|
Net periodic benefit cost (benefit)
|
$
|
(7,126
|
)
|
$
|
(2,395
|
)
|
|
$
|
(194
|
)
|
$
|
(414
|
)
|
|
(1)
|
Benefit plans, net
, which is presented separately in the Condensed Consolidated Statements of Operations, is not allocated to the segments.
|
|
(2)
|
Service cost related to a small group of active participants is presented within
cost of operations
in the Condensed Consolidated Statement of Operations and is allocated to the Babcock & Wilcox segment.
|
|
|
March 31, 2020
|
||||||||
|
(in thousands)
|
A-3
|
A-4
|
Total
|
||||||
|
Proceeds
(1)
|
$
|
101,660
|
|
$
|
30,000
|
|
$
|
131,660
|
|
|
Discount and fees
|
8,650
|
|
—
|
|
8,650
|
|
|||
|
Paid-in-kind interest
|
3,020
|
|
—
|
|
3,020
|
|
|||
|
Principal
|
113,330
|
|
30,000
|
|
143,330
|
|
|||
|
Unamortized discount and fees
|
(7,227
|
)
|
—
|
|
(7,227
|
)
|
|||
|
Net debt balance
|
$
|
106,103
|
|
$
|
30,000
|
|
$
|
136,103
|
|
|
|
December 31, 2019
|
||
|
(in thousands)
|
A-3
|
||
|
Proceeds
(1)
|
$
|
101,660
|
|
|
Discount and fees
|
8,650
|
|
|
|
Paid-in-kind interest
|
3,020
|
|
|
|
Principal
|
113,330
|
|
|
|
Unamortized discount and fees
|
(9,377
|
)
|
|
|
Net debt balance
|
$
|
103,953
|
|
|
|
Three months ended March 31,
|
|||||
|
(in thousands)
|
2020
|
2019
|
||||
|
Components associated with borrowings from:
|
|
|
||||
|
U.S. Revolving Credit Facility
|
$
|
4,039
|
|
$
|
3,550
|
|
|
Last Out Term Loans - cash interest
|
4,048
|
|
513
|
|
||
|
Last Out Term Loans - paid-in-kind interest
|
—
|
|
1,060
|
|
||
|
|
8,087
|
|
5,123
|
|
||
|
Components associated with amortization or accretion of:
|
|
|
||||
|
U.S. Revolving Credit Facility - deferred financing fees and commitment fees
|
9,035
|
|
5,270
|
|
||
|
U.S. Revolving Credit Facility - deferred ticking fee for Amendment 16
(1)
|
1,658
|
|
—
|
|
||
|
Last Out Term Loans - discount and financing fees
|
2,150
|
|
590
|
|
||
|
|
12,843
|
|
5,860
|
|
||
|
|
|
|
||||
|
Other interest expense
|
1,161
|
|
151
|
|
||
|
|
|
|
||||
|
Total interest expense
|
$
|
22,091
|
|
$
|
11,134
|
|
|
(1)
|
An incremental monthly fee of
1.0%
of total availability of the U.S. Revolving Credit Facility shall be earned on the 15th day of each month and is payable on the earlier of March 15, 2020 or the last day of the Availability Period with respect to the U.S. Revolving Credit Facility.
|
|
(in thousands)
|
March 31, 2020
|
December 31, 2019
|
March 31, 2019
|
December 31, 2018
|
||||||||
|
Held by foreign entities
|
$
|
27,937
|
|
$
|
38,921
|
|
$
|
26,746
|
|
$
|
35,522
|
|
|
Held by U.S. entities
|
7,447
|
|
4,851
|
|
16,781
|
|
7,692
|
|
||||
|
Cash and cash equivalents of continuing operations
|
35,384
|
|
43,772
|
|
43,527
|
|
43,214
|
|
||||
|
|
|
|
|
|
||||||||
|
Reinsurance reserve requirements
|
5,779
|
|
9,318
|
|
2,841
|
|
11,768
|
|
||||
|
Restricted foreign accounts
|
3,107
|
|
3,851
|
|
4,118
|
|
5,297
|
|
||||
|
Bank guarantee collateral
|
2,115
|
|
—
|
|
—
|
|
—
|
|
||||
|
Restricted cash and cash equivalents
|
11,001
|
|
13,169
|
|
6,959
|
|
17,065
|
|
||||
|
Total cash, cash equivalents and restricted cash shown in the Condensed Consolidated Statements of Cash Flows
|
$
|
46,385
|
|
$
|
56,941
|
|
$
|
50,486
|
|
$
|
60,279
|
|
|
|
Three months ended March 31,
|
|||||
|
(in thousands)
|
2020
|
2019
|
||||
|
Income tax payments (refunds), net
|
$
|
793
|
|
$
|
(78
|
)
|
|
|
|
|
||||
|
Interest payments on our U.S. Revolving Credit Facility
|
$
|
4,150
|
|
$
|
2,403
|
|
|
Interest payments on our Last Out Term Loans
|
4,038
|
|
540
|
|
||
|
Total cash paid for interest
|
$
|
8,188
|
|
$
|
2,943
|
|
|
(in thousands)
|
Currency translation
gain
|
Net unrecognized loss related to benefit plans (net of tax)
|
Total
|
||||||
|
Balance at December 31, 2019
|
$
|
5,743
|
|
$
|
(3,817
|
)
|
$
|
1,926
|
|
|
Other comprehensive income (loss) before reclassifications
|
2,380
|
|
—
|
|
2,380
|
|
|||
|
Reclassified from AOCI to net income (loss)
|
—
|
|
(246
|
)
|
(246
|
)
|
|||
|
Net other comprehensive income (loss)
|
2,380
|
|
(246
|
)
|
2,134
|
|
|||
|
Balance at March 31, 2020
|
$
|
8,123
|
|
$
|
(4,063
|
)
|
$
|
4,060
|
|
|
(in thousands)
|
Currency translation
(loss) gain
|
Net unrealized gain (loss)
on derivative instruments
(1)
|
Net unrecognized loss related to benefit plans
(net of tax)
|
Total
|
||||||||
|
Balance at December 31, 2018
|
$
|
(10,834
|
)
|
$
|
1,362
|
|
$
|
(1,960
|
)
|
$
|
(11,432
|
)
|
|
Other comprehensive income (loss) before reclassifications
|
10,260
|
|
(1,178
|
)
|
—
|
|
9,082
|
|
||||
|
Reclassified from AOCI to net income (loss)
|
—
|
|
224
|
|
(356
|
)
|
(132
|
)
|
||||
|
Net other comprehensive income (loss)
|
10,260
|
|
(954
|
)
|
(356
|
)
|
8,950
|
|
||||
|
Balance at March 31, 2019
|
$
|
(574
|
)
|
$
|
408
|
|
$
|
(2,316
|
)
|
$
|
(2,482
|
)
|
|
AOCI component
|
Line items in the Condensed Consolidated Statements of Operations affected by reclassifications from AOCI
|
Three months ended March 31,
|
|||||
|
2020
|
2019
|
||||||
|
Derivative financial instruments
|
Other – net
|
|
(289
|
)
|
|||
|
|
Provision for income taxes
|
—
|
|
(65
|
)
|
||
|
|
Net loss
|
$
|
—
|
|
$
|
(224
|
)
|
|
|
|
|
|
||||
|
Amortization of prior service cost on benefit obligations
|
Benefit plans, net
|
$
|
246
|
|
$
|
356
|
|
|
|
Provision for income taxes
|
—
|
|
—
|
|
||
|
|
Net income
|
$
|
246
|
|
$
|
356
|
|
|
(in thousands)
|
|
|
|
||||||
|
Available-for-sale securities
|
March 31, 2020
|
Level 1
|
Level 2
|
||||||
|
Corporate notes and bonds
|
$
|
8,689
|
|
$
|
8,689
|
|
$
|
—
|
|
|
Mutual funds
|
528
|
|
—
|
|
528
|
|
|||
|
United States Government and agency securities
|
6,442
|
|
6,442
|
|
—
|
|
|||
|
Total fair value of available-for-sale securities
|
$
|
15,659
|
|
$
|
15,131
|
|
$
|
528
|
|
|
(in thousands)
|
|
|
|
||||||
|
Available-for-sale securities
|
December 31, 2019
|
Level 1
|
Level 2
|
||||||
|
Corporate notes and bonds
|
$
|
8,310
|
|
$
|
8,310
|
|
$
|
—
|
|
|
Mutual funds
|
587
|
|
—
|
|
587
|
|
|||
|
United States Government and agency securities
|
3,868
|
|
3,868
|
|
—
|
|
|||
|
Total fair value of available-for-sale securities
|
$
|
12,765
|
|
$
|
12,178
|
|
$
|
587
|
|
|
•
|
Cash and cash equivalents and restricted cash and cash equivalents
. The carrying amounts that we have reported in the accompanying Condensed Consolidated Balance Sheets for cash and cash equivalents and restricted cash and cash equivalents approximate their fair values due to their highly liquid nature.
|
|
•
|
Revolving debt and Last Out Term Loans
. We base the fair values of debt instruments on quoted market prices. Where quoted prices are not available, we base the fair values on Level 2 inputs such as the present value of future cash flows discounted at estimated borrowing rates for similar debt instruments or on estimated prices based on current yields for debt issues of similar quality and terms. The fair value of our debt instruments approximated their carrying value at
March 31, 2020
and
December 31, 2019
.
|
|
•
|
Warrants.
The fair value of the warrants was established using the Black-Scholes option pricing model value approach.
|
|
(in thousands)
|
March 31, 2020
|
December 31, 2019
|
||||
|
Accounts receivable – trade, net
|
$
|
4,133
|
|
$
|
5,472
|
|
|
Accounts receivable – other
|
143
|
|
147
|
|
||
|
Contracts in progress
|
580
|
|
586
|
|
||
|
Inventories
|
1,884
|
|
1,555
|
|
||
|
Other current assets
|
298
|
|
329
|
|
||
|
Current assets held for sale
|
7,038
|
|
8,089
|
|
||
|
|
|
|
||||
|
Net property, plant and equipment
|
6,444
|
|
6,534
|
|
||
|
Intangible assets
|
711
|
|
725
|
|
||
|
Right-of-use-asset
|
24
|
|
63
|
|
||
|
Other assets
|
20
|
|
—
|
|
||
|
Non-current assets held for sale
|
7,199
|
|
7,322
|
|
||
|
|
|
|
||||
|
Total assets held for sale
|
$
|
14,237
|
|
$
|
15,411
|
|
|
|
|
|
||||
|
Accounts payable
|
$
|
6,340
|
|
$
|
7,898
|
|
|
Accrued employee benefits
|
495
|
|
430
|
|
||
|
Advance billings on contracts
|
353
|
|
227
|
|
||
|
Accrued warranty expense
|
509
|
|
515
|
|
||
|
Operating lease liabilities
|
3
|
|
6
|
|
||
|
Other accrued liabilities
|
586
|
|
462
|
|
||
|
Current liabilities held for sale
|
8,286
|
|
9,538
|
|
||
|
|
|
|
||||
|
Non-current liabilities held for sale
|
36
|
|
—
|
|
||
|
|
|
|
||||
|
Total liabilities held for sale
|
$
|
8,322
|
|
$
|
9,538
|
|
|
(i)
|
the maturity date of the revolving credit facility will be extended to June 30, 2022, and the maturity date of all Last Out Term Loans under the A&R Credit Agreement will be extended to December 30, 2022 (six months after the maturity date of the revolving credit facility);
|
|
(ii)
|
the interest rate for loans under the revolving credit facility will be reduced to LIBOR plus
7.0%
or base rate (as defined in the A&R Credit Agreement) plus
6.0%
. These margins will be reduced by
2.0%
if commitments under the revolving credit facility are reduced to less than
$200.0 million
. The fee for letters of credit will be set at
4.0%
;
|
|
(iii)
|
the interest rate for all Last Out Term Loans will be set at
12.0%
;
|
|
(iv)
|
the commitments under the revolving credit facility will automatically and permanently decrease in the following amounts on the following dates, which match the funding dates and amounts for the committed term loans: (x)
$10.0 million
on November 30, 2020; and (y)
$5.0 million
on each of March 31, 2021, June 30, 2021, September 30, 2021, December 31, 2021 and March 31, 2022, respectively;
|
|
(v)
|
the amount of revolving loans and letters of credit available in currencies other than U.S. dollars will be capped at
$125.0 million
through April 30, 2021 and step down to
$110.0 million
on May 1, 2021; and
|
|
(vi)
|
the amount of financial letters of credit will be capped at
$75.0 million
, and the amount of all letters of credit will be capped at
$190.0 million
through April 30, 2021 and step down to
$175.0 million
on May 1, 2021 (the “L/C Sublimit”).
|
|
•
|
$2.0 million
and
$6.1 million
of restructuring and spin-off costs were recognized in the first quarter of 2020 and 2019, respectively. The restructuring costs primarily related to severance in the first quarter of 2020 and 2019, respectively.
|
|
•
|
$0.9 million
and
$4.0 million
of financial advisory service fees were recorded in the first quarter of 2020 and 2019, respectively, which are required under our U.S. Revolving Credit Facility. Financial advisory service fees are included in
advisory fees and settlement costs
in the Condensed Consolidated Statement of Operations.
|
|
•
|
$6.6 million
of settlement cost was recognized in the first quarter of 2019 in connection with an additional European waste-to-energy EPC contract, for which notice to proceed was not given and the contract was not started and is included in
advisory fees and settlement costs
in the Condensed Consolidated Statement of Operations. The settlement limits our obligations to our core scope activities and eliminates risk related to acting as the prime EPC should the project have moved forward.
|
|
•
|
$2.6 million
and
$3.1 million
of legal and other advisory fees were recognized in the first quarter of 2020 and 2019, respectively, related to the contract settlement and for liquidity planning and is included in
advisory fees and settlement costs
in the Condensed Consolidated Statement of Operations. The contract settlement is further described above and in
Note 4
to the
Condensed Consolidated Financial Statements
.
|
|
•
|
$2.0 million
of accelerated depreciation expense in the first quarter of 2019 for fixed assets affected by our September 2018 announcement to consolidate office space and relocate our global headquarters to Akron, Ohio in December 2019.
|
|
•
|
$0.4 million
of actuarially determined mark to market ("MTM") losses on our pension and other post-retirement benefits in the first quarter of 2019. MTM losses are further described in
Note 12
to the
Condensed Consolidated Financial Statements
.
|
|
|
Three months ended March 31,
|
||||||||
|
(In thousands)
|
2020
|
2019
|
$ Change
|
||||||
|
Revenues:
|
|
|
|
||||||
|
Babcock & Wilcox segment
|
$
|
121,956
|
|
$
|
188,558
|
|
$
|
(66,602
|
)
|
|
Vølund & Other Renewable segment
|
15,309
|
|
29,532
|
|
(14,223
|
)
|
|||
|
SPIG segment
|
11,337
|
|
28,902
|
|
(17,565
|
)
|
|||
|
Eliminations
|
(48
|
)
|
(15,056
|
)
|
15,008
|
|
|||
|
|
$
|
148,554
|
|
$
|
231,936
|
|
$
|
(83,382
|
)
|
|
|
Three months ended March 31,
|
||||||||
|
(in thousands)
|
2020
|
2019
|
$ Change
|
||||||
|
Adjusted EBITDA
(1)
|
|
|
|
||||||
|
Babcock & Wilcox segment
|
$
|
10,654
|
|
$
|
9,089
|
|
$
|
1,565
|
|
|
Vølund & Other Renewable segment
|
(3,293
|
)
|
(8,789
|
)
|
5,496
|
|
|||
|
SPIG segment
|
(1,192
|
)
|
658
|
|
(1,850
|
)
|
|||
|
Corporate
|
(4,143
|
)
|
(4,591
|
)
|
448
|
|
|||
|
Research and development costs
|
(1,341
|
)
|
(743
|
)
|
(598
|
)
|
|||
|
|
$
|
685
|
|
$
|
(4,376
|
)
|
$
|
5,061
|
|
|
|
Three months ended March 31,
|
||||||||
|
(in thousands)
|
2020
|
2019
|
$ Change
|
||||||
|
Adjusted gross profit (loss)
(1)
|
|
|
|
|
|||||
|
Operating loss
|
$
|
(10,298
|
)
|
$
|
(31,962
|
)
|
$
|
21,664
|
|
|
Selling, general and administrative ("SG&A") expenses
|
37,532
|
|
42,269
|
|
(4,737
|
)
|
|||
|
Advisory fees and settlement costs
|
4,239
|
|
13,610
|
|
(9,371
|
)
|
|||
|
Amortization expense
|
1,410
|
|
1,187
|
|
223
|
|
|||
|
Restructuring activities and spin-off transaction costs
|
1,951
|
|
6,079
|
|
(4,128
|
)
|
|||
|
Research and development costs
|
1,341
|
|
743
|
|
598
|
|
|||
|
Gain on asset disposals, net
|
(915
|
)
|
—
|
|
(915
|
)
|
|||
|
|
$
|
35,260
|
|
$
|
31,926
|
|
$
|
3,334
|
|
|
|
Three months ended March 31,
|
||||||||
|
(in thousands)
|
2020
|
2019
|
$ Change
|
||||||
|
Adjusted gross profit (loss)
|
|
|
|
||||||
|
Babcock & Wilcox segment
|
$
|
32,881
|
|
$
|
31,106
|
|
$
|
1,775
|
|
|
Vølund & Other Renewable segment
|
1,458
|
|
(2,856
|
)
|
4,314
|
|
|||
|
SPIG segment
|
921
|
|
3,676
|
|
(2,755
|
)
|
|||
|
|
$
|
35,260
|
|
$
|
31,926
|
|
$
|
3,334
|
|
|
|
Three months ended March 31,
|
||||||||
|
(In thousands)
|
2020
|
2019
|
$ Change
|
||||||
|
Revenues
|
$
|
121,956
|
|
$
|
188,558
|
|
$
|
(66,602
|
)
|
|
Adjusted EBITDA
|
$
|
10,654
|
|
$
|
9,089
|
|
$
|
1,565
|
|
|
Adjusted gross profit
|
$
|
32,881
|
|
$
|
31,106
|
|
$
|
1,775
|
|
|
Adjusted gross profit %
|
27.0
|
%
|
16.5
|
%
|
|
||||
|
|
Three months ended March 31,
|
||||||||
|
(in thousands)
|
2020
|
2019
|
$ Change
|
||||||
|
Revenues
|
$
|
15,309
|
|
$
|
29,532
|
|
$
|
(14,223
|
)
|
|
Adjusted EBITDA
|
$
|
(3,293
|
)
|
$
|
(8,789
|
)
|
$
|
5,496
|
|
|
Adjusted gross profit (loss)
|
$
|
1,458
|
|
$
|
(2,856
|
)
|
$
|
4,314
|
|
|
Adjusted gross profit (loss) %
|
9.5
|
%
|
(9.7
|
)%
|
|
||||
|
|
Three months ended March 31,
|
||||||||
|
(In thousands)
|
2020
|
2019
|
$ Change
|
||||||
|
Revenues
|
$
|
11,337
|
|
$
|
28,902
|
|
$
|
(17,565
|
)
|
|
Adjusted EBITDA
|
$
|
(1,192
|
)
|
$
|
658
|
|
$
|
(1,850
|
)
|
|
Adjusted gross profit
|
$
|
921
|
|
$
|
3,676
|
|
$
|
(2,755
|
)
|
|
Adjusted gross profit %
|
8.1
|
%
|
12.7
|
%
|
|
||||
|
|
Three months ended March 31,
|
|||||
|
(In approximate millions)
|
2020
|
2019
|
||||
|
Babcock & Wilcox
|
$
|
159
|
|
$
|
187
|
|
|
Vølund & Other Renewable
(1)
|
18
|
|
19
|
|
||
|
SPIG
|
32
|
|
12
|
|
||
|
Other/eliminations
|
—
|
|
(2
|
)
|
||
|
Bookings
|
$
|
209
|
|
$
|
216
|
|
|
|
Three months ended March 31,
|
|||||
|
(In approximate millions)
|
2020
|
2019
|
||||
|
Babcock & Wilcox
|
$
|
257
|
|
$
|
384
|
|
|
Vølund & Other Renewable
(1)
|
190
|
|
317
|
|
||
|
SPIG
|
60
|
|
70
|
|
||
|
Other/eliminations
|
(6
|
)
|
(5
|
)
|
||
|
Backlog
|
$
|
501
|
|
$
|
766
|
|
|
(1)
|
Vølund & Other Renewable backlog at March 31, 2020, includes $160.0 million related to long-term operation and maintenance contracts for renewable energy plants, with remaining durations extending until 2034. Generally, such contracts have a duration of 10-20 years and include options to extend.
|
|
(In approximate millions)
|
2020
|
2021
|
Thereafter
|
Total
|
||||||||
|
Babcock & Wilcox
|
$
|
130
|
|
$
|
105
|
|
$
|
22
|
|
$
|
257
|
|
|
Vølund & Other Renewable
|
25
|
|
20
|
|
145
|
|
190
|
|
||||
|
SPIG
|
29
|
|
16
|
|
15
|
|
60
|
|
||||
|
Other/eliminations
|
(6
|
)
|
—
|
|
—
|
|
(6
|
)
|
||||
|
Expected revenue from backlog
|
$
|
178
|
|
$
|
141
|
|
$
|
182
|
|
$
|
501
|
|
|
|
Three months ended March 31,
|
||||||||
|
(In thousands, except for percentages)
|
2020
|
2019
|
$ Change
|
||||||
|
Loss before income taxes
|
$
|
(34,345
|
)
|
$
|
(49,240
|
)
|
$
|
14,895
|
|
|
Income tax (benefit) expense
|
$
|
(810
|
)
|
$
|
626
|
|
$
|
(1,436
|
)
|
|
Effective tax rate
|
2.4
|
%
|
(1.3
|
)%
|
|
||||
|
•
|
entered into several amendments and waivers to avoid default and improve our liquidity under the terms of our Amended Credit Agreement as described in
Note 13
and
Note 14
, the most recent of which were Amendments No. 19, No. 20 and No. 21 dated January 17, 2020, January 31, 2020 and March 27, 2020, respectively;
|
|
•
|
on January 31, 2020, received
$30.0 million
of additional gross borrowings from B. Riley Financial, Inc. (together with its affiliates, "B. Riley") under a new Tranche A-4 of Last Out Term Loans, as described in in
Note 14
;
|
|
•
|
on January 31, 2020, received an incremental Tranche A-5 of Last Out Term Loan commitment to be used in the event certain customer letters of credit are drawn, as described in
Note 14
;
|
|
•
|
on March 12, 2020, filed for waiver of required minimum contributions to the U.S. Pension Plan as described in
Note 12
, that if granted, would reduce cash funding requirements in 2020 by approximately
$25.0 million
and would increase contributions over the following five years. The Company cannot make any assurances that such waiver will be granted; and
|
|
•
|
on March 17, 2020, we fully settled the remaining escrow associated with the sale of Palm Beach Resource Recovery Corporation and received
$4.5 million
in cash.
|
|
•
|
on April 6, 2020, we fully settled the remaining escrow associated with the sale of the MEGTEC and Universal businesses and received
$3.5 million
in cash;
|
|
•
|
in April 2020, as part of the Company’s recent response to the impact of the COVID-19 pandemic on its business, the Company has taken the following cash conservation and cost reduction measures which include:
|
|
◦
|
temporarily deferring the monthly fee paid to BRPI Executive Consulting, LLC for the services of our Chief Executive Officer by
50%
;
|
|
◦
|
deferrals of the base salaries of our Chief Strategy Officer by
50%
, Chief Financial Officer by
30%
and our Senior Vice President of The Babcock & Wilcox Company by
30%
;
|
|
◦
|
approval by the Company’s Board for a temporary deferral of
50%
of the cash compensation payable to non-employee directors under the Company’s board compensation program to be paid during the first quarter of 2021;
|
|
◦
|
negotiating temporary rent payment deferrals related to leased facilities located in the U.S., Canada, Italy and Denmark;
|
|
◦
|
exploring options for government loans and programs in the U.S. and abroad that would be appropriate and available;
|
|
•
|
we elected to defer, in accordance with the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") signed into law in March 2020, the contribution payment of
$5.5 million
for the 2020 Plan year that would have been made on April 15, 2020; and
|
|
•
|
on May 14, 2020, the Company entered into an agreement with its lenders amending and restating the Amended Credit Agreement, among the Company, Bank of America, N.A., as administrative agent (the “Administrative Agent”) and lender, and the other lenders party thereto. The credit agreement, as amended and restated (the "A&R Credit Agreement"), among other amendments, extends the maturity date on the revolving credit facility to June 30, 2022 and the maturity date on the Last Out Term Loans to December 30, 2022. Under the A&R Credit Agreement, B. Riley has committed to provide the Company with up to
$70.0 million
of additional Last Out Term Loans. B. Riley has also agreed to enter into a limited guaranty (the "B. Riley Guaranty") which provides for the guarantee of all of the Company's obligations with respect to the revolving credit facility (other than with respect to letters of credit and contingent obligations), including the obligation to repay outstanding revolving credit loans and pay earned interest and fees.
|
|
•
|
The 2019 Rights Offering, for which B. Riley agreed to act as a backstop, by purchasing from us, at a price of
$0.30
per share, all unsubscribed shares in the 2019 Rights Offering for cash or by exchanging an equal principal amount of outstanding Tranche A-2 or Tranche A-3 Last Out Term Loans (the "Backstop Commitment"). Under the 2019 Rights Offering,
16,666,666
shares of common stock were issued, of which
12,589,170
shares were purchased through the exercise of rights in the rights offering generating
$37.8 million
of cash,
1,333,333
shares were issued through assigned portions of the Backstop Commitment generating an additional
$4.0 million
of cash, and the final
2,744,163
shares were exchanged for
$8.2 million
of principal value including accrued paid-in-kind interest of Tranche A-3 Last Out Term Loans.
|
|
•
|
$10.3 million
of the proceeds of the 2019 Rights Offering were used to fully repay Tranche A-2 of the Last Out Term Loans, including accrued paid-in-kind interest.
|
|
•
|
$31.5 million
of the proceeds of the 2019 Rights Offering were used to partially prepay Tranche A-3 of the Last Out Term Loans including paid-in-kind interest. The total prepayment of principal of Tranche A-3 of the Last Out Term Loans was
$39.7 million
inclusive of the
$8.2 million
of principal value exchanged for common shares under the Backstop Commitment described above.
|
|
•
|
All
$38.2 million
of outstanding principal of Tranche A-1 of the Last Out Term Loans including accrued paid-in-kind interest was exchanged for
12,720,785
shares of common stock (
10,720,785
shares to Vintage and
2,000,000
shares to B. Riley) at a price of
$0.30
per share (the "Debt Exchange"). Prior to the Debt Exchange,
$6.0 million
of Tranche A-1 was held by B. Riley and the remainder was held by Vintage.
|
|
•
|
1,666,667
warrants, each to purchase one share of our common stock at an exercise price of
$0.01
per share were issued to B. Riley.
|
|
(i)
|
the maturity date of the revolving credit facility will be extended to June 30, 2022, and the maturity date of all Last Out Term Loans under the A&R Credit Agreement will be extended to December 30, 2022 (six months after the maturity date of the revolving credit facility);
|
|
(ii)
|
the interest rate for loans under the revolving credit facility will be reduced to LIBOR plus
7.0%
or base rate (as defined in the A&R Credit Agreement) plus
6.0%
. These margins will be reduced by
2.0%
if commitments under the revolving credit facility are reduced to less than
$200.0 million
. The fee for letters of credit will be set at
4.0%
;
|
|
(iii)
|
the interest rate for all Last Out Term Loans will be set at
12.0%
;
|
|
(iv)
|
the commitments under the revolving credit facility will automatically and permanently decrease in the following amounts on the following dates, which match the funding dates and amounts for the committed term loans: (x)
$10.0 million
on November 30, 2020; and (y)
$5.0 million
on each of March 31, 2021, June 30, 2021, September 30, 2021, December 31, 2021 and March 31, 2022, respectively;
|
|
(v)
|
the amount of revolving loans and letters of credit available in currencies other than U.S. dollars will be capped at
$125.0 million
through April 30, 2021 and step down to
$110.0 million
on May 1, 2021; and
|
|
(vi)
|
the amount of financial letters of credit will be capped at
$75.0 million
, and the amount of all letters of credit will be capped at
$190.0 million
through April 30, 2021 and step down to
$175.0 million
on May 1, 2021 (the “L/C Sublimit”).
|
|
(share data in thousands)
|
|
|
|
|
||||||
|
Period
|
Total number of shares purchased
(1)
|
Average price paid per share
|
Total number of shares purchased as part of publicly announced plans or programs
|
Approximate dollar value of shares that may yet be purchased under the plans or programs
|
||||||
|
January 2020
|
—
|
|
$
|
—
|
|
—
|
|
$
|
—
|
|
|
February 2020
|
1,230
|
|
$
|
3.64
|
|
—
|
|
$
|
—
|
|
|
March 2020
|
1,232
|
|
$
|
4.17
|
|
—
|
|
$
|
—
|
|
|
Total
|
2,462
|
|
$
|
3.91
|
|
—
|
|
$
|
—
|
|
|
|
Rule 13a-14(a)/15d-14(a) certification of Chief Executive Officer.
|
|
|
|
|
|
|
|
Rule 13a-14(a)/15d-14(a) certification of Chief Financial Officer.
|
|
|
|
|
|
|
|
Section 1350 certification of Chief Executive Officer.
|
|
|
|
|
|
|
|
Section 1350 certification of Chief Financial Officer.
|
|
|
|
|
|
|
10.1
*
|
|
Amendment and Restatement Agreement (attaching the Amended and Restated Credit Agreement), dated as of May 14, 2020, among Babcock & Wilcox Enterprises, Inc., as the borrower, Bank of America, N.A., as Administrative Agent, and the other lenders party thereto (incorporated by reference to Exhibit 10.1 of the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed May 15, 2020 (File No. 001-36876)).
|
|
|
|
|
|
|
Fee Letter, dated as of May 14, 2020, among Babcock & Wilcox Enterprises, Inc. and B. Riley Financial, Inc. (incorporated by reference to Exhibit 10.2 of the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed May 15, 2020 (File No. 001-36876)).
|
|
|
|
|
|
|
|
Fee and Interest Equitization Agreement, dated May 14, 2020, between Babcock & Wilcox Enterprises, Inc., B. Riley Financial, Inc. and, solely for limited purposes under the Equitization Agreement, B. Riley FBR, Inc. (incorporated by reference to Exhibit 10.3 of the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed May 15, 2020 (File No. 001-36876)).
|
|
|
|
|
|
|
|
Termination Agreement, dated as of May 14, 2020, between Babcock & Wilcox Enterprises, Inc. and B. Riley Financial, Inc. and acknowledged by Bank of America, N.A. (incorporated by reference to Exhibit 10.4 of the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed May 15, 2020 (File No. 001-36876)).
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document.
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
|
|
|
|
BABCOCK & WILCOX ENTERPRISES, INC.
|
|
|
|
|
|
May 15, 2020
|
By:
|
/s/ Louis Salamone
|
|
|
|
Louis Salamone
|
|
|
|
Executive Vice President, Chief Financial Officer and Chief Accounting Officer
(Principal Financial and Accounting Officer and Duly Authorized Representative)
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|